Myeloma

Top Story

High-frequency basal cell carcinoma may signal increased risk for other cancers

High-frequency basal cell carcinoma may signal increased risk for other cancers
January 7, 2019
Meeting News

Triplet combinations with pomalidomide improve response vs. doublet combinations in myeloma

January 5, 2019
SAN DIEGO — Triplet combination regimens containing pomalidomide nearly doubled response rates compared with doublet combination regimens of pomalidomide in…
In the JournalsPerspective

SLE linked to increased risk for 16 cancers, decreased risk for melanoma

January 2, 2019
Systemic lupus erythematosus is associated with an increased risk for 16 cancers, including Hodgkin’s and non-Hodgkin’s lymphoma, leukemia and multiple…
In the Journals Plus

Carfilzomib regimen extends multiple myeloma survival, regardless of renal impairment

December 27, 2018
The combination of carfilzomib and dexamethasone extended PFS and OS compared with bortezomib and dexamethasone among patients with relapsed or refractory multiple…
More Headlines »
CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Video
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »
Resource Centers
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »